Anticholinergic drugs and bone health in rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Injuries & trauma, Skin clinical trials.
This study looks at whether a type of medication (anticholinergic drugs) used for other conditions affects bone health in people with rheumatoid arthritis. It will help doctors understand if these drugs increase the risk of osteoporosis (weak bones) and if they should be avoided.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rheumatoid arthritis.
- You do not have other diseases that affect bone metabolism (like Paget's disease, hyperparathyroidism, or chronic kidney disease).
- You are not taking medications that affect bone health (such as corticosteroids, bisphosphonates, or hormone therapy).
- You do not have metal implants in your hip or lower back that could interfere with a bone density scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how rheumatoid arthritis relates to bone thinning and muscle loss in people over 50. It aims to find what factors are linked to these conditions.
This study looks at whether calcium in the heart arteries and a blood test (troponin) can help predict heart disease risk in people with rheumatoid arthritis. It may help doctors better prevent heart attacks and strokes.
This trial looks at how two types of rheumatoid arthritis (RA) medications affect patients. It aims to compare anti-TNF drugs with other RA drugs to see if one type is better.
This study looks at what makes people with rheumatoid arthritis more likely to develop an irregular heartbeat. It may help doctors identify who is at higher risk and potentially prevent serious heart problems in the future.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
This study looks at how rheumatoid arthritis is linked to osteoporosis (weakening of bones). It aims to understand what factors contribute to this connection.
Hear when a new Fractures, Bone trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.